nalmefene: Clinical Trials

9 trials of nalmefene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 withdrawn, 1 recruiting. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 6, Withdrawn 2, Recruiting 1
Phase 21Completed 1

Follow nalmefene: new trials by email Literature Review of nalmefene trials Research Report on nalmefene

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose
Nalmefene Injection, Naloxone Injection - Opioid Overdose, Opiate Overdose
Phase 3WithdrawnUniversity of New Mexico2024-08-262025-02-10
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
Nalmefene, Placebo - Behavioural Addiction
Phase 3RecruitingNantes University Hospital2662023-03-312025-02-12
Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.
Nalmefene (Selincro®) 18 mg tablet, placebo - Cirrhosis, Alcohol Dependence
Phase 3WithdrawnCentre Hospitalier Universitaire, Amiens2018-12-012023-07-20
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
Nalmefene hydrochloride - Alcohol Dependence
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.4052015-07-132020-07-20
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
Nalmefene hydrochloride, Placebo - Alcohol Dependence
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.6782015-02-092019-09-30
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
Placebo, Nalmefene - Alcohol Dependence
Phase 3CompletedH. Lundbeck A/S6652009-03-012013-08-07
Efficacy of Nalmefene in Patients With Alcohol Dependence
Placebo, Nalmefene - Alcohol Dependence
Phase 3CompletedH. Lundbeck A/S6782009-03-012013-07-22
Efficacy of Nalmefene in Patients With Alcohol Dependence
Placebo, Nalmefene - Alcohol Dependence
Phase 3CompletedH. Lundbeck A/S5982008-12-012013-07-09
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
nalmefene HCl, Placebo - Pathological Gambling
Phase 2 / Phase 3CompletedSomaxon Pharmaceuticals2332005-08-012008-05-19

Conditions studied

Alcoholism (6)  ·  Alcohol-Related Disorders (3)  ·  Mental Disorders (3)  ·  Gambling (2)  ·  Compulsive Sexual Behavior Disorder (1)  ·  Drug Overdose (1)  ·  Fibrosis (1)  ·  Food Addiction (1)  ·  Opiate Overdose (1)  ·  Respiratory Insufficiency (1)

Sponsors

H. Lundbeck A/S (3)  ·  Otsuka Pharmaceutical Co., Ltd. (2)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Nantes University Hospital (1)  ·  Somaxon Pharmaceuticals (1)  ·  University of New Mexico (1)

Countries

France (3)  ·  Czechia (2)  ·  Japan (2)  ·  Poland (2)  ·  Austria (1)  ·  Belgium (1)  ·  Estonia (1)  ·  Finland (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Caitlin Bonney, MD (1)  ·  Osamu Sato (1)  ·  Philip Jochelson, MD (1)

Results publications

PMID 25227627, PMID 23873853, PMID 25832297, PMID 23237314, PMID 23562264